Tiziana Life Sciences : StemPrintER Demonstrates Prognostic Utility in TransATAC Cohort
New York, March 1, 2022 - Tiziana Life Sciences Ltd. reports that its' former subsidiary, AccuStem Sciences, Inc. , today announced publication of new data in the European Journal of Cancer.... | March 1, 2022